Adele Kay Fielding
Impact in
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
- Hematology 92
- Chronic Myeloid Leukemia Treatments 60
- Acute Myeloid Leukemia Research 26
- Hematopoietic Stem Cell Transplantation 21
-
- Acute Lymphoblastic Leukemia research 97
- Co-authors
- Anthony H. Goldstone (37 shared papers)Jacob M. Rowe (23 shared papers)Martin S. Tallman (20 shared papers)Georgina A. N. Buck (17 shared papers)Mark Robert Litzow (20 shared papers)David Ian Marks (26 shared papers)Andrew McMillan (18 shared papers)Selina M. Luger (15 shared papers)
- Journals
- Blood (49 papers)British Journal of Haematology (15 papers)Leukemia (9 papers)Journal of Clinical Oncology (7 papers)Bone Marrow Transplantation (7 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Adele Kay Fielding
162 papers receiving 12.7k citations
Adele Kay Fielding's Hit Papers
Peers
Comparison fields: 5 of 120
- Hematology 5.5k
- Public Health, Environmental and Occupational Health 6.5k
- Oncology 4.2k
- Genetics 1.1k
- Pediatrics, Perinatology and Child Health 1.7k
Countries citing papers authored by Adele Kay Fielding
This map shows the geographic impact of Adele Kay Fielding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele Kay Fielding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele Kay Fielding more than expected).
Fields of papers citing papers by Adele Kay Fielding
This network shows the impact of papers produced by Adele Kay Fielding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele Kay Fielding. The network helps show where Adele Kay Fielding may publish in the future.
Co-authors
The 25 scholars most cited alongside Adele Kay Fielding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia Hit paper breakdown → | 2017 | 1693 |
| 2 | Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study Hit paper breakdown → | 2014 | 1068 |
| 3 | Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Hit paper breakdown → | 2006 | 688 |
| 4 | In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) Hit paper breakdown → | 2007 | 657 |
| 5 | Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial Hit paper breakdown → | 2006 | 614 |
| 6 | Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study Hit paper breakdown → | 2017 | 358 |
| 7 | Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2016 | 344 |
| 8 | 2009 | 326 | |
| 9 | 2007 | 314 | |
| 10 | 2013 | 301 | |
| 11 | 2009 | 287 | |
| 12 | 2009 | 237 | |
| 13 | 2016 | 236 | |
| 14 | 2001 | 215 | |
| 15 | 2019 | 212 | |
| 16 | 1997 | 207 | |
| 17 | 1996 | 186 | |
| 18 | 2012 | 179 | |
| 19 | 2016 | 171 | |
| 20 | 2022 | 132 |
About Adele Kay Fielding
Adele Kay Fielding is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Genetics and Pediatrics, Perinatology and Child Health, having authored 168 papers that have together received 13.0k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (97 papers), Chronic Myeloid Leukemia Treatments (60 papers), Acute Myeloid Leukemia Research (26 papers), Childhood Cancer Survivors' Quality of Life (22 papers), Hematopoietic Stem Cell Transplantation (21 papers), Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (19 papers) and Virus-based gene therapy research (18 papers). The work is most often cited by research in Hematology (5.5k citations), Public Health, Environmental and Occupational Health (6.5k citations), Oncology (4.2k citations), Genetics (1.1k citations) and Pediatrics, Perinatology and Child Health (1.7k citations). Adele Kay Fielding has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anthony H. Goldstone, Jacob M. Rowe, Martin S. Tallman, Georgina A. N. Buck, Mark Robert Litzow, David Ian Marks, Andrew McMillan, Selina M. Luger, Hillard Michael Lazarus and Anthony V. Moorman. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Journal of Clinical Oncology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.